These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2521276)

  • 1. Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von Willebrand factor and protein S.
    Takahashi H; Tatewaki W; Nakamura T; Hanano M; Wada K; Shibata A
    Am J Hematol; 1989 Jan; 30(1):14-21. PubMed ID: 2521276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
    Tatewaki W
    Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.
    Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
    Tersteeg C; Joly BS; Gils A; Lijnen R; Deckmyn H; Declerck PJ; Plaimauer B; Coppo P; Veyradier A; Maas C; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2017 Dec; 15(12):2432-2442. PubMed ID: 28981198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura.
    Moake JL; Rudy CK; Troll JH; Weinstein MJ; Colannino NM; Hong SL; Koutcher JA; Melaragno AJ; Manner CE
    Am J Med Sci; 1986 Jan; 291(1):47-50. PubMed ID: 3079954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura.
    Weinstein MJ; Blanchard R; Moake JL; Vosburgh E; Moise K
    Br J Haematol; 1989 May; 72(1):68-72. PubMed ID: 2786734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Murphy WG; Moore JC; Barr RD; Pai MK; Kelton JG
    Br J Haematol; 1987 Aug; 66(4):509-13. PubMed ID: 3499167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
    Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
    Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
    Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
    Moake JL; Byrnes JJ; Troll JH; Rudy CK; Hong SL; Weinstein MJ; Colannino NM
    Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters.
    Takahashi H; Takakuwa E; Yoshino N; Hanano M; Shibata A
    Thromb Haemost; 1985 Aug; 54(2):445-9. PubMed ID: 3841232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
    Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
    Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation.
    Yoo G; Blombäck M; Schenck-Gustafsson K; He S
    Br J Haematol; 2003 Apr; 121(1):123-9. PubMed ID: 12670342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.